Sort
48,018 grants matching “immunotherapy”
Small molecule enhancers of tumor immunity targeting the LPA5 GPCR
$861,845Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2022 · CA
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
$861,780Beth Israel Medical Ctr (New York) · U01 · FY2000 · AI
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy
$861,166Jyothi Rengarajan · Emory University · R01 · FY2022 · AI
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer
$861,087Matthew Reed · Nob Hill Therapeutics, Inc. · R44 · FY2023 · CA
Overcoming pre-existing immunity to AAV to enhance AAV-based HIV immunotherapies
$861,082Mauricio De Aguiar Martins · University Of Florida · R01 · FY2024 · AI
Viral priming and targeting NK cells against solid tumor malignancies
$860,921Jeffrey S Miller · University Of Minnesota · R35 · FY2019 · CA
Visualization hub for genomics data exploration and translational discovery
$860,716Jingchun Zhu · University Of California Santa Cruz · U24 · FY2020 · CA
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
$860,660Manuel L Penichet · University Of California Los Angeles · R01 · FY2018 · CA
CD4-Independent Vaccinations for Pulmonary Infections
$860,610Jay K Kolls · Lsu Health Sciences Center · P01 · FY2007 · HL
Bispecific Antibody Therapeutics for Neuroblastoma and Diffuse Midline Glioma
$860,018James M Olson · Seattle Children'S Hospital · U01 · FY2023 · CA
ALTERING THE TUMOR MICROENVIRONMENT TO AUGMENT NEUROBLASTOMA IMMUNOTHERAPY
$860,000The Children'S Hospital Of Philadelphia · · FY2018 · Department of the Army
Combined radio- and immunotherapy of aggressive NHL
$859,792William A. Wegener · Immunomedics, Inc. · R44 · FY2009 · CA
Immune Mechanisms, Genetic and Environmental Factors Influencing Outcomes
$859,788Scott H Sicherer · Icahn School Of Medicine At Mount Sinai · U19 · FY2011 · AI
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
$859,607Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2020 · CA
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$859,480Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA
Pediatric AIDS Clinical Trials Group
$859,411University Of California San Diego · U01 · FY2002 · AI
Combination Therapy with Semaglutide and Anti-Amyloid Antibodies for Alzheimers Disease
$859,410Cynthia A Lemere · Brigham And Women'S Hospital · R01 · FY2024 · AG
Translating cellular immunotherapies for autoimmunity to canine clinical trials
$859,159Aimee S Payne · University Of Pennsylvania · R01 · FY2020 · AR
Treatment of Autoimmune Disease by Costimulatory Signal*
$859,049Brigham And Women'S Hospital · U19 · FY2004 · AI
Study of CAR T cells and mechanisms of resistance in pediatric brain tumors
$858,635Anandani Nellan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Center for the Study of Innate Immunity to HCV Infection
$858,518Michael J Gale · University Of Washington · U19 · FY2012 · AI
Center for the Study of Innate Immunity to HCV Infection
$858,518Michael J Gale · University Of Washington · U19 · FY2014 · AI
Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy
$858,502Joshua Aiden Hill · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Regulation of innate lymphocyte function
$858,430Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Cytokine Gene Therapy of Cancer - Preclinical Studies
$858,309Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA